Genetic research
Metformin's Effect on Squamous Cell Carcinoma Questioned in New Research
Recent research has investigated the potential of metformin, a medication commonly used to treat type 2 diabetes, as a radiosensitizer for squamous cell carcinoma. The study, conducted by researchers from the University of Zurich, Bern University Hospital, and other institutions, aimed to determine whether metformin could reduce tumor hypoxia in